Cryoport, Inc., a global provider of supply chain solutions for the life sciences industry, has announced FDA registration of its subsidiary, MVE Biological Solutions, across three manufacturing facilities. The registered sites are located in Ball Ground, Georgia; New Prague, Minnesota;
Single Use Support has announced the appointment of Darren Verlenden as Chief Executive Officer, a strategic move to support the company’s ambitious global growth plans. Verlenden, who was previously Executive Vice President for the Process Solutions business at Merck KGaA
Cryoport, Inc., a global supply chain solutions provider for life sciences, has opened its new IntegriCell™ facility in Belgium to support cell therapy programs with cryopreservation services. The facility, located in Villers-le-Bouillet, aims to enhance the cryopreservation of leukapheresis materials,
Lakeside Holding Limited, a cross-border supply chain solutions provider focusing on the Asian market, has acquired Hupan Pharmaceutical (Hubei) Co., Ltd. Lakeside announced its acquisition of Hupan Pharmaceutical for RMB 4.0 million (approximately $0.6 million USD) through its subsidiary Sichuan
GenScript Biotech Corporation has announced the opening of a new operations site and logistics center in Sydney, Australia. This expansion aims to streamline the delivery of biotechnology research materials across the region, marking GenScript’s increased commitment to the Asia-Pacific market.
Southwest Research Institute (SwRI) has broken ground on a new 21,000-square-foot Clinical Supply Facility designed to support government and industry clients in pharmaceutical and bioengineering research and development. According to Darrel Johnston, director of SwRI’s Pharmaceutical and Bioengineering Department, “The
Cold Chain Technologies (CCT) has announced the acquisition of Tower Cold Chain, a UK-based provider of passive reusable cold chain solutions for temperature-sensitive life sciences products. Terms of the deal were not disclosed. Founded in 1999, Tower Cold Chain designs
Cryoport, Inc. has announced a new strategic partnership with VGXI, Inc., aimed at bolstering supply chain services for biopharmaceutical companies developing cell and gene therapies, as well as mRNA-based treatments. The collaboration will leverage Cryoport’s biostorage and bioservices to manage
Lipocine Inc., a biopharmaceutical company specialising in oral drug delivery technologies, has entered into an exclusive supply and distribution agreement with Pharmalink to commercialise TLANDO, its oral testosterone replacement therapy, across the Gulf Cooperation Council (GCC) region. The agreement covers
Resilience Government Services, a subsidiary of National Resilience, has secured approximately $17.5 million in funding to bolster domestic manufacturing of essential pharmaceutical components. The funding comes from the US Department of Health and Human Services’ (HHS) Administration for Strategic Preparedness
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
